Application of PBBM and virtual bioequivalence to support formulation development and define dissolution specification, two case studies

Authors: Nabais E, Martins F
Software: GastroPlus®
Division: PBPK

During this webinar, we will shed light on the key benefits and practical implications of utilizing in-silico modeling for formulation development, biopharmaceutical predictions, and bioequivalence studies. Our expert speakers will showcase two real-world examples, showcasing how these software tools have enhanced decision-making processes, accelerated drug development timelines, and improved product quality.

Eduardo Nabais
Manager, Dissolution and PBPK/PBBM Modeling Team
União Química

Frederico Martins
Principal Scientist & Scientific Lead (South America)
Simulations Plus